T regulatory cells, the evolution of targeted immunotherapy

被引：34
|
作者：
Nizar, S. [1 ,2 ]
Meyer, B. [1 ]
Galustian, C. [1 ]
Kumar, D. [2 ]
Dalgleish, A. [1 ]
机构：
[1] St Georges Univ London, Dept Cellular & Mol Med, London SW17 0RE, England
[2] St Georges Hosp NHS Trust, Dept Colorectal Surg, London, England
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2010年 / 1806卷 / 01期
关键词：
T regulatory; Tregs; FOXP3; Cancer; Immunotherapy; PHASE-II TRIAL; DENILEUKIN DIFTITOX; DENDRITIC CELLS; ANTITUMOR IMMUNITY; CTLA-4; BLOCKADE; TGF-BETA; PERIPHERAL-BLOOD; PROSTATE-CANCER; FUSION PROTEIN; IN-VITRO;
D O I：
10.1016/j.bbcan.2010.02.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
T regulatory cells are able to suppress anti-tumour immunity in pre-clinical models and in patients. This review highlights the important discoveries in Treg immunology critical to the evolution of targeted immunotherapy. We also describe the therapeutic applications that are currently being assessed and their future potential. (C) 2010 Elsevier BM. All rights reserved.
引用
收藏
页码：7 / 17
页数：11
相关论文
共 50 条
  • [41] Functional control of regulatory T cells and cancer immunotherapy
    Wang, RF
    SEMINARS IN CANCER BIOLOGY, 2006, 16 (02) : 106 - 114
  • [42] Expanding and converting regulatory T cells: a horizon for immunotherapy
    Khattar, Mithun
    Chen, Wenhao
    Stepkowski, Stanislaw M.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2009, 57 (03) : 199 - 204
  • [43] Follicular regulatory T cells: a novel target for immunotherapy?
    Huang, Yao
    Chen, Zhe
    Wang, Hui
    Ba, Xin
    Shen, Pan
    Lin, Weiji
    Wang, Yu
    Qin, Kai
    Huang, Ying
    Tu, Shenghao
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (02)
  • [44] Targeting adenosine and regulatory T cells in cancer immunotherapy
    Churov, Alexey
    Zhulai, Galina
    HUMAN IMMUNOLOGY, 2021, 82 (04) : 270 - 278
  • [45] Regulatory T cells: a potential target in cancer immunotherapy
    Shitara, Kohei
    Nishikawa, Hiroyoshi
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1417 (01) : 104 - 115
  • [46] Regulatory T Cells for More Targeted Immunosuppressive Therapies
    Allos, Hazim
    Al Dulaijan, Basmah S.
    Choi, John
    Azzi, Jamil
    CLINICS IN LABORATORY MEDICINE, 2019, 39 (01) : 1 - +
  • [47] Targeted depletion of regulatory T cells in solid cancers
    Fisher, S.
    Solin, J.
    Aston, W.
    Cleaver, A.
    Lesterhuis, W. J.
    Khong, A.
    Robinson, B. W. S.
    Lake, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 231 - 231
  • [48] Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
    Grazyna Lipowska-Bhalla
    David E. Gilham
    Robert E. Hawkins
    Dominic G. Rothwell
    Cancer Immunology, Immunotherapy, 2012, 61 : 953 - 962
  • [49] Dual targeted CAR immunotherapy for neuroblastoma using γδ T cells
    Jonus, Hunter C.
    Lee, Jasmine Y.
    Silva, Jordan A.
    Spencer, H. Trent
    Goldsmith, Kelly C.
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
    Lipowska-Bhalla, Grazyna
    Gilham, David E.
    Hawkins, Robert E.
    Rothwell, Dominic G.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (07) : 953 - 962
12345